MELISSA TAYLOR: Open Payments
NPI 1982712436 · MORGANTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 78 payments from 19 companies in 2025. Trend: 2023 $2,125 · 2024 $1,594 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $243 |
| ABBVIE INC. | 18 | $211 |
| Teva Pharmaceuticals USA, Inc. | 9 | $139 |
| PFIZER INC. | 4 | $100 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Dexcom, Inc. | 2 | $51 |
| Corium, LLC | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Lilly USA, LLC | 2 | $36 |
Products named: VRAYLAR, AUSTEDO XR, Rybelsus, NURTEC ODT, Ozempic, Wegovy, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across NC — which companies pay providers there.
